What is LOPJLB’s current signal on FBRX?

LOPJLB’s latest quantitative signal on Forte Biosciences, Inc. (FBRX) is BUY in a BULL regime. Signals are updated daily.

What market regime is FBRX in?

Forte Biosciences, Inc. (FBRX) is currently classified in the BULL HMM market regime on LOPJLB.

What does Forte Biosciences, Inc. (FBRX) do?

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

Where is Forte Biosciences, Inc. based / listed?

Forte Biosciences, Inc. is based in US, listed on NASDAQ.

Forte Biosciences, Inc. (FBRX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$76.99+0.00%Close

BUYBULL · day 19

[SCORES & PROFILE]

FUND: 6
VALUE: 5
GROWTH: 39
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-56.9%

REV YoY-

ROE-94.8%

EPS YoY-

ROA-42.7%

GROSS

NET

[VALUATION]

P/E TTM-16.77

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B9.96

P/FCF-

EV/EBITDA-17.71

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO10.01

ND/EBITDA-

BETA2.65

Forte Biosciences, Inc. (FBRX)

Key stats

Prediction markets

FUNDAMENTALS

Company news